Home > Insider Trading > Filing (0001654954-22-015323)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1014763	Ainos Inc.	AIMD	Pharmaceutical Preparations (2834)	751974352

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1859356	Chung-Jung Tsai	8880 Rio San Diego Drive, Suite 800 San Diego CA 92108		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-12-20	8,932	$0.50	8,932	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	RSU	Acquisiton	2022-11-14	70,000	$0.00	70,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
70,000			No	4	A	Direct

Footnotes

The beneficially owned common stock was reported as 133,986 shares in a Form 4 filed on December 20, 2021 and has been adjusted herein to give effect to a 1-for-15 Reverse Stock Split effective August 8, 2022.
Reference is made to the RSUs granted under the 2021 Stock Incentive Plan. Each RSU represents a right to receive one (1) share of common stock upon vesting and the expiration of any applicable restricted period or, if approved, the cash value thereof (or any combination thereof). Holders of RSUs have no rights or privileges as a stockholder. Except as otherwise agreed, if the Reporting Person's participation is terminated for any reason prior to the date that all of its RSU have vested, all vesting rights shall cease and all unvested RSU shall be forfeited for no consideration as of the date termination. Vesting dates related to the 70,000 RSUs are as follows: 10,500 shares on 5/14/23 and 11/14/23, respectively, 21,000 shares on 11/14/24 and 28,000 shares on 11/14/25.